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CD43-independent augmentation of mouse T-cell function by
glycoprotein cleaving enzymes
Introduction
The age-related decline in immune function affects both
the innate (macrophage activation, dendritic cell migra-
tion, and Toll-like receptor-mediated activation);1,2 and
adaptive (T- and B-cell activation and germinal centre
formation)3–5 immune responses. There is, however, some
evidence that many of these defects are secondary to the
age-related decline in T-cell function;6,7. Age-dependent
defects in the T-cell compartment are well documented
and thought to reflect both changes in T-cell subset com-
position, and defects in the activation processes within
the peripheral T-cell pool.8,9 These defects lead to a
decline in lymphocyte proliferation10 and deregulation
in the production of cytokines, including interleukin-2
(IL-2).11 Evidence suggests that these functional age-rela-
ted defects are the result of upstream transcriptional flaws
caused by earlier signalling deficiencies that take place
shortly after activation.3,12
Recent work has shown that the age-related decline in
T-cell receptor (TCR) signalling may be due to defects
in the very earliest stages of T-cell activation, involving
reorganization of the cytoskeleton and formation of the
immunological synapse.12 Studies focusing on the res-
ponse of TCR-transgenic CD4+ cells to antagonist pep-
tide sequences have shown that aged T cells exhibit defects
in cytoskeletal rearrangement that contribute to synapse
formation but precede peptide recognition by the TCR.12
Age-dependent cytoskeletal defects also lead to a failure,
in aged CD4+ cells, to remove CD43 from the site of T
cell/antigen-presenting cell (APC) interaction.13 CD43, a
large and heavily glycosylated molecule, has been estima-
ted to cover 28% of the T-cell surface. Its extracellular
domain is approximately 45 nm in length, making it both
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Summary
Previous work has shown that the function of mouse CD4+ T cells can be
augmented by an enzyme, O-sialoglycoprotein endopeptidase (OSGE),
which cleaves surface CD43, suggesting the idea that the high levels of
glycosylated CD43 found on T cells from aged mice may contribute to
immune senescence. New results now show that OSGE improves T-cell
function even in mice lacking CD43, showing that other glycoproteins
must contribute to the OSGE effect on function. Evaluation of other
enzymes found two whose ability to stimulate CD4 activation was higher
in aged than in young T cells. One of these, PNGase F, is a glycosidase
specific for N-linked glycans, and the other, ST-Siase(2,3) from Salmonella
typhimurium, is specific for a2,3-linked terminal sialic acid residues. Par-
allel lectin-binding experiments showed that removal of a2,3-linked sialic
acid residues vulnerable to PNGase F and ST-Siase(2,3) was also greater
in old than in young T cells. The preferential ability of PNGase F and
ST-Siase(2,3) to improve the function of T cells from aged mice may
involve cleavage of glycoproteins containing a2,3-linked sialic acid resi-
dues on N-linked or O-linked glycans or both.
Keywords: ageing; immunosenescence; signal transduction; cellular activa-
tion; glycosylation
Abbreviations: CP-Siase, Clostridium perfringens-derived sialidase; Endo H, Endogycosidase H; OSGE, O-sialoglycoprotein
endopeptidase; PNGase F, Peptide-N-Glycosidase F; ST-Siase(2,3), Salmonella typhimurium-derived sialidase; VC-Siase,
Vibrio cholerae-derived sialidase.
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the most abundant and the largest protein on the sur-
face of the T cell.14 In some model systems, CD43 seems
to act as a negative regulator in T-cell adhesion and
activation.15–17 Data from our laboratory have illustrated
that there is an age-dependent increase in specific glycosyl
determinants (S7 and 1B11) on the CD43 molecule, and
that high level expression of S7 and 1B11 is seen prefer-
entially on a T-cell subset, marked by P-glycoprotein, that
is known to be anergic to most forms of stimulation.13 In
addition, we have shown that age-dependent defects in
synapse formation in old CD4+ T cells can be corrected
by treating the cells with O-sialoglycoprotein endopepti-
dase (OSGE), which cleaves the peptide backbone of
O-linked glycoproteins, including CD43.13 Pre-treatment
of the T cells with OSGE without stimulation did not
result in cellular activation.13,18 Collectively, these obser-
vations suggest the hypothesis that the proteolytic clea-
vage of glycosylated CD43 molecules by OSGE is
responsible for augmentation of cytokine production and
calcium response in young T cells, and for the restoration
of these signals and synapse formation by CD4+ cells of
aged mice.
Our initial studies of OSGE included tests using another
enzyme, the sialidase from Vibrio cholerae (VC-Siase), to
see if the effects of OSGE might be due to the elimination
of terminal sialic acid residues, and showed that VC-Siase
had no effect on synapse formation by young or old
T cells.13 A follow-up study, however, showed that a second
sialidase from Clostridium perfringens (CP-Siase), did
improve T-cell function in cells from both young and old
mice.19 Like OSGE, pretreatment of the T cells with
CP-Siase without stimulation did not result in cellular
activation.19 Both VC-Siase and CP-Siase can cleave both
a2,3- and a2,6-linked terminal sialic acid residues from a
wide range of proteins. The difference in their functional
effects was our point of departure for using glycosidases of
narrower specificity to potentially shed light on the basis
for age-related T-cell activation defects and the mechanism
by which glycoprotein-specific hydrolases can augment
function in both young and old T cells.
Materials and methods
Mice
CD43 knockout (KO) and CD43 wild type (WT) mice, on
the C57BL/6 background, were a gift from Dr Anne
Sperling (University of Chicago). Specific pathogen-free
male (BALB/cJ · C57BL/6 J)F1 (CB6F1) mice were pur-
chased from the National Aging Institute contract colonies.
Mice were considered young at 3–6 months of age, and old
at 20–26 months of age. All CD43 KO mice and their WT
controls were used when young. Mice were given free access
to food and water. Sentinel animals were examined quar-
terly for serological evidence of viral infection; all such tests
were negative during the course of these studies. Mice with
splenomegaly or macroscopically visible tumours at the
time of death were not used for experiments.
Antibodies and reagents
Antibodies to mouse anti-CD3e (clone 145-2C11) and
anti-CD28 (clone 37.51) were produced in our laboratory.
All monoclonal antibodies for flow cytometry were pur-
chased from BD Biosciences (San Diego, CA). The lectins
were purchased from E-Y Laboratories (San Mateo,
CA). OSGE was purchased from Cedarlane Laboratories
(Hornby, Ontario, Canada). CP-Siase and VC-Siase were
purchased from Roche (Indianapolis, IN). Recombinant
Salmonella typhimurium sialidase [ST-Siase(2,3)], peptide-
N-glycosidase F (PNGase F) and endoglycosidase H
(Endo H) expressed in Escherichia coli were purchased
from New England Biolabs (Beverly, MA). Recombinant
sialidase L and ceramide-glycase, both from Macrobdella
decora, were purchased from V-Laboratories (Covington,
LA). Endoglycoceramidase II was purchased from Takara
Bio (Shiga, Japan).
Cell preparation, enzymatic treatment, and CD69
and CD25 flow cytometric analysis
T cells and CD4+ T cells were obtained as previously des-
cribed.20 Flow cytometric analysis of a typical preparation
showed it to be 90–95% positive for the population of
interest. The purified T cells or CD4+ T cells (1 · 106
cells/ml in Hanks’ balanced salt solution (HBSS)) were
incubated with 50 lg/ml of OSGE (1 hr), 100 mU/ml of
CP-Siase (or the control enzymes endoglycoceramidase I,
Macrobdella decora ceramide-glycase or VC-Siase) (1 hr),
1500 U/ml of PNGase F (or the control enzyme Endo H)
(12 hr) or 250 U/ml of ST-Siase(2,3) (12 hr) or at 37.
Cells were stimulated with anti-CD3 (aCD3) and the
expression of CD69 and CD25 was examined by flow
cytometry as previously described.13 Quantification was
done using the mean fluorescence intensity (MFI).
Measurement of cytosolic Ca2+
Cytosolic Ca2+ measurement was performed as previously
described.18 Splenic T cells (either untreated or pretreated
with OSGE), were loaded with Indo-1 AM (25 lM;
Molecular Probes, Eugene, OR) at room temperature for
30 min, washed and then stained with an anti-CD4
(clone RM4-5) or anti-CD8 (clone 53-6.7) antibody. The
calcium mobilization assay was conducted at 37 on a
FACSVantage flow cytometer using FACSDiva software
(BD Biosciences, San Jose, CA). Baseline levels were col-
lected for 20 s, after which the cells were stimulated with
5 lg/ml of non-cross-linked anti-CD3 (clone 145-2C11).
Each assay was performed for a 5-min period. The
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CD4+ T-cell enhancement is not CD43 dependent
acquired data were analysed using FlowJo’s kinetic
platform (TreeStar, Ahsland, OR). Each histogram dis-
plays the mean of the violet/blue ratio as a function of
time with smoothing for moving average.
Cytokine enzyme-linked immunosorbent assay (ELISA)
Purified CD4+ T cells were stimulated for 6 hr in culture
with aCD3 at 1 lg/ml or with aCD3 plus aCD28 at
1 lg/ml each. Supernatants were collected and stored at
)70 until cytokine analysis. IL-2, IL-4 and interferon-c
(IFN-c) were quantified using commercial enzyme-linked
immunosorbent assay kits (BioSource International,
Camarillo, CA) according to the manufacturer’s proto-
cols. The minimum detectable level was <8 pg/ml for
IL-2, <1 pg/ml for IFN-c, and <5 pg/ml for IL-4.
Lectin binding assays to cell surface proteins and
flow cytometry
Lectin binding and CD4+ T-cell surface marker expression
were analysed by flow cytometry using three-colour stain-
ing assays as previously described.19 Purified T cells were
incubated with antibodies against CD4 (Cy-Chrome
labelled) for 30 min in HBSS (containing 02% bovine
serum albumin and 01%NaN3) on ice, washed twice, and
incubated with fluoroscein isothiocyanate (FITC)-conju-
gated lectins at 1 lg/ml for 30 min at room temperature,
washed twice, and analysed by flow cytometry.
Statistical analysis
In the case of Ca2+ assays, the peak increase above base-
line was calculated for CD4+ and CD8+ T cells, with the
data then subjected to a two-tailed Mann–Whitney test.
Cytokine data were analysed using a Friedman ANOVA,
with post hoc analysis done using Wilcoxon matched pairs
tests. CD69, CD25 and lectin binding data were analysed
using a two-way ANOVA. Post-hoc analysis was done using
Dunnett’s 2-sided multiple comparison test. Ageing com-
parisons (young versus old) were analysed using paired
t-tests. In order to evaluate if a treatment had a differen-
tial effect on a group (either WT versus KO or young
versus old), the absolute change of each mouse in the
group was calculated after treatment and the groups were
compared using paired t-tests. Comparisons were deemed
significant when P ¼ 005.
Results
OSGE enhances Ca2+ responses of CD4+ and
CD8+ T cells even in CD43 KO mice
We have previously shown18 that OSGE cleaves the
O-linked glycoprotein CD43 and increases aCD3-induced
Ca2+ responses in CD4+ T cells of both young and old
mice. To determine if the cleavage of CD43 is required
for this effect, we evaluated the Ca2+ response of CD43
KO mice and their littermate controls. Figure 1 shows a
representative experiment. Pre-treatment of the T cells
with OSGE without stimulation did not result in calcium
influx. Untreated cells from WT and CD43 KO mice
mount similar responses (CD4+: P ¼ 048; CD8+: P ¼
034). Pre-treatment with OSGE significantly enhanced
the aCD3-induced Ca2+ response in CD4+ as well as
CD8+ T cells from both WT (CD4+: P ¼ 002; CD8+:
P ¼ 005) and CD43 KO (CD4+: P ¼ 002; CD8+: P ¼
002) mice, showing that the effect of OSGE on cells from
young mice does not require CD43.
OSGE enhances cytokine production by CD4+ T cells
from young CD43 KO mice
Our previous data have shown that OSGE enhances the
production of IL-2 and IFN-c by CD4+ T cells from
young and old mice.18 To determine if these effects of
OSGE are mediated through cleavage of CD43 alone, we
evaluated the production of IL-2, IFN-c, and IL-4 by
CD4+ T cells from CD43 KO mice in responses stimula-
ted by soluble aCD3 (CD3s; left panels of Fig. 2) or by
CD3s plus aCD28 (right panels). Cytokine secretion was
measured by ELISA 6 hr after stimulation. The CD43 KO
and CD43 WT mice were on the C57BL/6 background,
while previous experiments were performed on CB6F1
mice.18 In our hands, CD4+ T cells from C57BL/6 mice
produced lower amounts of cytokines as compared to






























Figure 1. Effect of OSGE on the calcium response. CD4+ (top
panel) and CD8+ (bottom panel) T cell Ca2+ responses were induced
by non-cross-linked anti-CD3 in WT and CD43 KO mice, with or
without pretreatment by OSGE. The break in each line shows where
stimulatory antibodies were added after 20 s of baseline data collec-
tion. The graphs are representative of the data obtained from four
WT and four CD43 KO mice from four independent experiments.
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OSGE without stimulation did not result in the produc-
tion of any cytokines (data not shown). In no case did
untreated cells from the CD43 KO mice make signifi-
cantly more cytokine than untreated control cells. In all
cases, treatment with OSGE led to significant increases
(P < 005) in cytokine production by both WT and CD43
KO cells. OSGE did not have a differential effect on WT
or CD43 KO mice, except in the case of IL-4 after CD3s
stimulation, where OSGE had a greater effect (P ¼ 005)
on T cells from WT mice. These data, like the calcium
results, suggest that the stimulatory effect of OSGE on
young CD4+ cells does not depend upon cleavage of
CD43.
Treatment with OSGE can enhance the expression
of early activation markers in both WT and
CD43 KO mice
We also evaluated the effects of OSGE on the expression
of CD69 at 6 hr, and CD25 at 24 hr after activation in
both CD4+ and CD8+ T cells. The results are shown in
Fig. 3. Pre-treatment of the T cells with OSGE without
stimulation did not result in the expression of CD69 or
CD25 (data not shown). The CD69 data showed that
OSGE led to a significant enhancement (P < 001) in
both CD4+ and CD8+ T cells of both CD43 KO and WT
mice. There were no significant differences between
responses of WT and CD43 KO mice, either in untreated
or in OSGE-treated cells. Although modestly significant
(P ¼ 001) differences were seen between WT and KO
cells in the effect of OSGE, these differences are quite
small, and the expression of CD69 on OSGE-treated cells
was essentially equivalent. For CD25 expression, measured
at a later time point, the effects of OSGE were consistent
but less dramatic than in the CD69 data, and reached sta-
tistical significance for CD4+ responses in WT mice and
CD8+ responses in CD43 KO mice (P < 002 in each
case) but not for the other comparisons (P < 01) shown
in Fig. 3. There were no differences in OSGE effect on
CD25 expression in either CD4+ or CD8+ cells.
Inhibition of CD69 and CD25 expression by
2,3-linked sialic acid residues and N-linked
oligosaccharides in CD4+ T cells of old and young
mice
The studies of CD43 KO mice were motivated by our
hypothesis18 that CD43 cleavage by OSGE was largely
responsible for the ability of this enzyme to improve mul-
tiple aspects of function in CD4+ T cells of both young
and old mice. The evidence that OSGE has strong effects
on T-cell function even in CD43 KO mice prompted a
search for other glycoprotein-specific enzymes that might
have similar functional effects, perhaps by alteration of
an overlapping set of surface macromolecules. Figure 4
shows the results with two such enzymes, ST-Siase(2,3)
and PNGase F, using CD69 and CD25 expression as indi-
ces of CD4+ and CD8+ T cell function. ST-Siase(2,3) is
a sialidase isolated from Salmonella typhimurium, and
is specific for 2,3-linked Gal/GalNAc groups. Peptide-
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Figure 2. OSGE enhances IL-2, IFN-c, and IL-4 production in WT
and CD43 KO mice. CD4+ T cells (106) /ml from WT (dark bars)
and CD43 KO (light bars) mice were either treated with OSGE or
left untreated, and stimulated with aCD3, or aCD3 plus aCD28
(aCD3 + aCD28). The supernatants were collected after 6 h of sti-
mulation and analysed for IL-2 (top two panels), IFN-c (middle two
panels), and IL-4 (bottom two panels) by ELISA. The bars represent
the mean ± SEM from six WT and six CD43 KO mice from six
independent experiments. Asterisks (*) indicate significant difference



























Figure 3. OSGE enhances early activation marker expression in
CD43 KO mice. T cells from WT (dark bars) and CD43 KO (light
bars) mice were treated with OSGE or left untreated, and then sti-
mulated with aCD3. Gated CD4+ or CD8+ T cells were examined
for CD69 (top two panels) expression after 6 hr of stimulation, and
for CD25 (bottom two panels) 24 hr after stimulation. The bars rep-
resent the mean ± SEM from six WT and six CD43 KO mice from
six independent experiments. Asterisks (*) indicate significant differ-
ence with untreated mice of the same group (WT or CD43 KO).
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CD4+ T-cell enhancement is not CD43 dependent
the links between the innermost GlcNAc and asparagine
residues of oligosaccharides from N-linked glycoproteins.
Pre-treatment of the T cells with ST-Siase(2,3) or PNGase
F without stimulation did not result in the expression of
CD69 or CD25 (data not shown). The CD69 data (top
panels) show, as expected, a small but significant age-
dependent decline in CD69 expression after 6 hr of sti-
mulation in both CD4+ (P ¼ 0001) and CD8+ (P ¼
0006) cells. We have shown previously,13,19 that OSGE or
CP-Siase treatment of CD4+ T cells from young and old
mice results in a significant increase in CD69 expression
after stimulation. The results in Fig. 4 confirm this for
CD4+ cells and show similar changes for CD8+ T cells
(both P < 005 for both cell types). After treatment with
either enzyme, responses of T cells from young and old
donors were statistically indistinguishable in the case of
both CD4+ and CD8+ cells. In agreement with our previ-
ous results19 treatment of the T cells with endoglyco-
ceramidase I or Macrobdella decora ceramide-glycase
(enzymes that remove sialic acid residues and polysac-
charide structures from surface glycolipids), and with
VC-Siase (another 2,3 and 2,6 sialidase, similar to CP-
Siase) did not result in enhanced expression of CD69 or
CD25 (data not shown), suggesting that the negative
regulation of the TCR response is dependent upon speci-
fic sialic acid residues present on specific glycoproteins.
Exposure to ST-Siase(2,3) induced a significant increase
(P < 005) in the ability to express CD69 in both CD4+
and CD8+ cells of old mice (Fig. 4, top panels); the
responses of cells from young donors were not enhanced
to a significant extent by this enzyme. The effect of
ST-Siase(2,3) was significantly stronger in old T cells than
in cells from young donors for both CD4+ (P ¼ 001)
and CD8+ (P ¼ 0008) subsets. Treatment with PNGase F
also improved CD69 expression in both CD4+ and CD8+
cells from both young and old mice. After treatment with
either enzyme, responses of T cells from aged and young
donors were statistically indistinguishable. However, treat-
ment with Endo H, another amidase which cleaves within
the chitobiose core of high mannose and some hybrid
oligosaccharides from N-linked glycoproteins, had no
effect on CD69 expression in either CD4+ or CD8+ cells
from young or old donors (data not shown). These
results suggest that specific N-glycosylated moieties on
surface glycoproteins are responsible for the inhibition of
TCR signal.
Similar results were found in the analysis of CD25
expression after 24 hr of aCD3 stimulation (Fig. 4, bot-
tom panels). There was a significant age-dependent
decline in CD25 expression after activation (P ¼ 0001
for CD4+ cells, P ¼ 001 for CD8+). Treatment with
ST-Siase(2,3) or PNGase F also produced significant
enhancement of CD25 expression in CD4+ and CD8+ T
cells from young and old mice (P < 005 for both sub-
sets). For CD4+ cells, both enzymes had a larger effect in
old T cells than in young ones (ST-Siase(2,3) P ¼ 004;
PNGase F P ¼ 003). For CD8+ cells, the effects were
also larger in cells from old mice, but the age effect did
not reach statistical significance (ST-Siase(2,3) P ¼ 006,
PNGase F (P ¼ 009).
ST-Siase(2,3) and PNGase F enhance production
of IL-2 and IFN-c
Figure 5 shows the outcome of experiments in which
CD4+ T cells were treated with these enzymes and then
tested for the production of cytokines after 6 h of stimu-
lation. Pre-treatment of the T cells with ST-Siase(2,3) or
PNGase F without stimulation did not result in cytokine
production (data not shown). Treating CD4+ cells from
young mice with ST-Siase(2,3) had no significant effect
on IL-2 production (Fig. 5, top panel), but this enzyme
did lead to a significant (P ¼ 003) enhancement of IL-2
production by T cells of old mice. PNGase F also
increased IL-2 production from both young and old mice
(P < 003). The enhancements observed after PNGase F
treatment were significantly greater in the T cells from
the aged mice as compared to their young counterparts
(ST-Siase(2,3) P ¼ 001; PNGase F P ¼ 002). Produc-
tion of IFN-c, a cytokine whose production by mouse
CD4+ increases with age, was also augmented by both
ST-Siase(2,3) and PNGase F in both young and old ani-
mals (Fig. 5, bottom; P < 003 for each effect). There was
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Figure 4. ST-Siase(2,3) and PNGase F enhance early activation
marker expression in CD4+ and CD8+ T cells from young and old
mice. T cells from young (dark bars) and old (light bars) mice were
treated with OSGE, CP-Siase, ST-Siase(2,3) or PNGase F, or left
untreated, and then stimulated with aCD3. Gated CD4+ or CD8+ T
cells were examined for CD69 (top panels) expression after 6 hr of
stimulation, and for CD25 (bottom panels) 24 hr after stimulation.
The bars represent the mean ± SEM from six young and six old
mice from six independent experiments. Asterisks (*) indicate signifi-
cant difference with untreated mice of the same age group (young or
old). (a) and (b) indicate significant effects of age.
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IFN-c production to a greater extent in old than in young
mice, but the differences were not statistically significant:
the responses to ST-Siase(2,3) were 36-fold higher in old
mice (P ¼ 014) and the responses to PNGase F were
21-fold higher (P ¼ 007).
Lectin binding analysis after treatment with
ST-Siase(2,3) and PNGase F
To learn more about the cell surface glycoproteins whose
cleavage by OSGE, CP-Siase, ST-Siase(2,3) or PNGase F
improve T-cell function, we evaluated the binding of anti-
bodies and lectins to CD4+ cells before and after enzyme
exposure using flow cytometry. Figure 6 shows these results
for both young and old mice. The S7 antibody recognizes a
sialylated polysaccharide determinant found on the CD43
molecule on all resting T lymphocytes. Confirming our
previously published data13 we noted (top panel) an age-
dependent increase in the mean fluorescence intensity of
the S7 determinant (P < 0001). Both OSGE and CP-Siase
caused significant reductions in S7 levels on CD4+ cells
from young or old mice (P < 005). ST-Siase(2,3) and
PNGase F, however, did not diminish S7 binding, even at
concentrations that do augment several aspects of CD4+
T-cell function. These data suggest that removal of the S7
determinant of CD43 is not required for enzyme-mediated
enhancement of CD4+ T cell function.
Sambucus nigra type-1 (SNA-I) lectin specifically recog-
nizes a(2,6) linkages of sialic acid to galactose. The
middle panel of Fig. 6 shows, in good agreement with
our previous results19 a significant age-related decline
in SNA-I binding to the surface of CD4+ T cells
(P < 0001). This decline is independent of the naı̈ve to
memory shift that takes place with ageing (data not
shown19). As expected, the positive control (CP-Siase)
drastically lowered SNA-I binding in CD4+ cells from
young and old animals. Treatment with ST-Siase(2,3)
OSGE or PNGase F, in contrast, did not change SNA-I
binding to CD4+ cells from young and old mice. The
results suggest that the enhancement of T cell function by
these three enzymes are not due to changes in the a(2,6)-
Siase content of surface glycoproteins.
The Maackia amurensis lectin (MAA) recognizes 2,3-
linked sialic acid residues.19 As is shown in Fig. 6 (bottom
panel), MAA binding to CD4+ cells increases slightly
with age; the change is about 25%, but is not statistically
significant (P ¼ 008) in the current study. Separate
analyses found that the age-dependent increase in MAA
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Figure 6. Analysis of S7 and lectin binding in CD4+ T cells from
young and old donors. T cells from young (dark bars) and old (light
bars) mice were treated with the indicated enzymes and then incuba-
ted with aCD4 and with either FITC-S7 (top panel), SNA-I (middle
panel), or MAA (bottom panel). Gated CD4+ cells were then ana-
lysed by flow cytometry. Bars represent the mean fluorescence inten-
sity ± SEM of 10 young and 10 old mice from 10 independent
experiments. Asterisks (*) indicate significant difference with
untreated mice of the same age group (young or old). Letters (a)































Figure 5. ST-Siase(2,3) and PNGase F enhance cytokine expression
in CD4+ T cells from young and old mice. 106 CD4+ T cells/ml from
young (dark bars) and old (light bars) mice were either treated with
ST-Siase(2,3) or PNGase F, or left untreated, and then stimulated
with aCD3 plus aCD28. The supernatants were collected after 6 hr
of stimulation and analysed for IL-2 (top panel), and IFN-c (bottom
panel) by ELISA. The bars represent mean ± SEM from six young
and six old mice from six independent experiments. Asterisks (*)
indicate significant difference with untreated mice of the same age
group (young or old). Letters (a) and (b) indicate significant effects
of age.
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CD4+ T-cell enhancement is not CD43 dependent
not shown). Figure 6 shows that CP-Siase significantly
reduced MAA binding in young and in old CD4+ T cells.
In contrast, OSGE, ST-Siase(2,3) and PNGase F dimin-
ished MAA binding sites in CD4+ cells of old mice only;
these three enzymes did not alter MAA binding in cells
derived from young mice. This age-specific difference in
the biochemical effects of ST-Siase(2,3) and PNGase F
suggests that the functional effects of these enzymes may
depend on removal of specific 2,3-linked terminal sialic
acid residues rather than on a global change in cell
surface sialic acid content, and suggest that the specific
residues whose removal augments function may be more
prevalent on old than on young CD4+ cells.
Discussion
Our previous work has shown that OSGE-mediated pro-
teolytic cleavage of the external domains of O-linked sialo-
glycoproteins restores the ability of CD4+ T cells from
aged donors to form immunological synapses. OSGE also
enhances the ability of CD4+ T cells from young and old
mice to mobilize calcium, express early activation markers
and secrete various cytokines after stimulation.13,18,19 We
also found similar enhancements in T-cell function using a
sialidase from Clostridium perfringens (CP-Siase) that
removes terminal sialic acid residues, but did not see func-
tional changes in T cells treated with other modulators of
sialic acid residues including VC-Siase, or the glycolipid-
specific enzymes endoglycoceramidase I or Macrobdella
decora ceramide-glycase.19 These results suggested a model
in which T cells from both young and old animals contain
specific polysaccharide moieties on the cell surface that
can inhibit T-cell signalling and function, and in which
ageing leads to further changes in the amount or relative
levels of these inhibitory glycoproteins. In this model,
treatment with OSGE and CP-Siase is postulated to
remove some of these polysaccharide determinants, leaving
the T cells from young and old donors with similar pat-
terns of glycosylation on their surface and similar levels of
function.
Several lines of circumstantial evidence suggested that
OSGE-mediated cleavage of CD43 was a major compo-
nent of the OSGE effect. CD43, also called sialophorin, is
a large glycoprotein and is expressed at high levels on the
T-cell surface.21 Most published data suggest that CD43 is
a negative regulator of T-cell activation, but its function
is still somewhat controversial. It has been shown that the
presence of CD43 interferes with T-cell adhesion,16,17,22
perhaps through interfering with leucocyte function-
associated antigen-1 binding to intracellular adhesion
molecule-1, and treatment of cells with a neuraminidase
decreases this anti-adhesion effect.15 CD43 has also been
shown to negatively regulate rolling in T cells23 and T-cell
homing.22 In some studies, T cells from CD43 KO mice
have shown a marked increase in their in vitro ability
to proliferate in response to several forms of stimula-
tion, both TCR-mediated and receptor-independent,16,24
In vivo analyses using CD43 KO mice illustrated that
these mice were hyper-responsive to keyhole-limpet
haemocyanin (KLH) immunization and a delayed-type
hypersensitivity (DTH) response to trimellitic anhydride
(TMA), showed increased antibody titres following
immunization with sheep red blood cells and displayed
an augmented antiviral cytotoxic T cell response.16,24
These negative regulatory effects exerted by CD43 are
suspected to be the result of steric hindrance or electro-
static repulsion mediated by the large extracellular
domain of CD43,25 but there is also evidence showing
that the intracellular portion of CD43 can negatively
regulate T-cell function.26
In contrast to these reports, other work has shown that
CD43 plays a positive role in T-cell activation by facilita-
ting the emigration of leucocytes into tissues23 and by act-
ing as a costimulator of T-cell activation,27,28 particularly
in memory cells.29 Another study reported that T cells
from CD43 KO animals displayed no substantial or consis-
tent hyper-responsive pattern to stimulation.30 Our own
data finds no evidence that T cells from CD43 KO animals
are hyper-responsive when compared to WT controls,
although we note that our protocols use antibodies rather
than antigen-bearing APCs as the means of stimulation.
Our own work13 had shown an age-dependent increase
in the S7 and 1B11 determinants of CD43, a decline with
age in the relocation of CD43 away from the synapse after
T-cell activation, and that cells with high expression of S7
and 1B11 were in an anergic subset marked by the
expression of P-glycoprotein. Taken together, these data
suggested that functional defects of T cells from old
donors might reflect the inhibitory effects of over-glyco-
sylated CD43 left within the synapse as a result of cyto-
skeletal defects.
Our new data show that OSGE augments the function
of both CD4+ and CD8+ T cells of young CD43 KO mice.
We did note that the effect of OSGE on CD69 expression
was greater in WT than in CD43 KO cells, suggesting that
CD43 may have effects on AP-1 mediated events, such
as expression of CD69,31 with less influence over other
events such as calcium influx and cytokine production.
Our work shows that CD43 does not play a major role in
inhibition of T cell function in young mice, although it is
possible that CD43 might contribute to inhibition of
function in T cells from aged animals.
What OSGE-sensitive surface glycoprotein(s), then,
inhibit the function of T cells from young mice? CD45 is
one obvious possibility. CD45 is, like CD43, a large,
abundant, and heavily O-glycosylated molecule shown to
exert both positive32 and negative33,34 effects in T-cell
activation. The smallest isoform of CD45, CD45RO, has a
relatively strong association with CD4-p56lck and the TCR
as compared to larger isoforms, and promotes enhanced
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phosphorylation of cellular activation proteins including
Vav, as well as IL-2 production.35,36 Unpublished data
from our laboratory have shown that OSGE is able to
cleave the larger isoforms of the CD45 molecule, while
leaving the CD45RO isoform intact, suggesting that OSGE
may function through this mechanism.
In addition to its glycosylation, CD45 is known to bear
large amounts of sialic acid. Previous work from our lab
has shown a large age-related increase in the amount
of Siaa(2,3)Gal/GalNAc on CD45 with age.19 Sialic acid
residues on the surface of CD45 may inhibit its interac-
tion with CD4 and thus diminish T-cell activation.
Removal of these inhibitory sialic acid residues from
CD45 using CP-Siase, might promote CD45–CD4 interac-
tion, leading to enhanced signalling and function.
Sialic acid residues of T-cell surface glycoproteins have
been shown to regulate the assembly of the TCR com-
plex37 and T cell apoptosis38 as well as the initial interac-
tions between T cells and APCs.39,40 Two varieties of
terminal sialic acid residues are found on T-cell glycopro-
teins, one containing an a2,3 linkage to an underlying
galactose or N-acetyl-galactosamine residue (Siaa(2,3)Gal/
GalNAc), and the other involving an a2,6 glycosidic link-
age (Siaa(2,6)Gal/GalNAc). Little is known about the dis-
tribution of these two forms of sialic acid residues among
T-cell surface glycoproteins, the effects of age on these
moieties, or the roles each may play in modulating early
events in T-cell activation. Our new data, using
ST-Siase(2,3) suggest that Siaa(2,3)Gal/GalNAc residues,
on proteins still to be determined, inhibit expression of
CD69 and CD25, as well as production of IL-2 and IFN-c
by CD4+ T cells from old animals. Interestingly,
ST-Siase(2,3) is significantly less effective in augmenting
CD69 expression and cytokine production in T cells from
young mice (Figs 4 and 5). These results suggest that age
may increase the proportion of functionally relevant
Siaa(2,3) links susceptible to cleavage, and indeed the
MAA results of Fig. 6 show that ST-Siase(2,3) is able to
diminish MAA binding sites in CD4+ T cells of old but
not of young mice. We do not know in what surface mol-
ecules those Siaa(2,3) links are located, but the enhance-
ment of the biological activity of CD4+ T cells by
treatment with PNGase F and not Endo H suggests that
some of these may be attached to specific N-linked gly-
cans. Consistent with this idea, we note that removal of
MAA-binding sites by PNGase F is significantly higher on
old than on young CD4+ cells (Fig. 6, bottom).
There is evidence from other laboratories that removing
N-linked sugars can lower the threshold of T cell activa-
tion. T cells from Mgat5 KO mice are deficient in
N-linked sugar branching and show a lowered threshold
for TCR-dependent tyrosine phosphorylation, calcium
mobilization, and T-cell proliferation in response to
extrinsic stimuli.41 It has also been shown that CD28
costimulation is negatively regulated by N-linked carbo-
hydrates.42 Thus although it is possible that the effects of
PNGase F on T-cell function reflect removal of terminal
sialic acid residues on specific N-linked glycans, it is also
plausible that the treatment may mimic the broad changes
seen in T cells of Mgat5 KO mice, or act through relieving
N-linked sugar restraints on costimulatory molecules.
Our data, showing OSGE-mediated functional effects
on CD43 KO mice and, conversely, functional effects of
enzymes that do not alter expression of the S7 determin-
ant of CD43 (Fig. 6), refute our original hypothesis
attributing OSGE effects largely to cleavage of CD43. The
SNA-I binding data also argue against the idea that
Siaa(2,6)Gal/GalNAc determinants play a crucial role in
dampening TCR signalling in CD4+ T cells from young
and old mice. Our results do not eliminate the possi-
bility that these determinants may participate in other
T-cell functions; such as apoptosis38 or T cell–APC
interactions.39
Additional experiments are under way to further eluci-
date which specific glycosylated molecules are involved in
dampening T-cell signalling and function in young and
old mice. Overall, our data further support the notion
that glycosylation plays an essential role in modulating
CD4+ T-cell signalling and function, and that an age-rela-
ted dysregulation in the expression of negative regulatory
glycosyl moieties, possibly including Siaa(2,3)Gal/GalNAc
residues, contributes to immunosenescence. Understand-
ing these phenomena may help us to explore new meth-
ods in restoring immune protection in the elderly.
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